Karen Drexler insider trades: Outset Medical (OM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Karen reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | OM | ↓ Sell | 1,548 | $4.37 | $7K | Direct | Dec 2, 2025 (1d) |
| Apr 29, 2024 | RMD | ↓ Sell | 425 | $214.92 | $91K | Direct | Apr 30, 2024 (1d) |
| Feb 2, 2023 | RMD | ↓ Sell | 594 | $226.58 | $135K | Direct | Feb 3, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OM insiders
Open-market trades in the last 12 months
About Karen Drexler's insider trades
Karen Drexler is a director at Outset Medical (OM). Since Feb 2, 2023, Karen has reported no open-market purchases and 3 sales worth $233K on SEC Form 4. In the last 12 months: 1 sale ($7K).
Their filings also include grants and awards (29 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.